Likewise, the knowledge of Rhein, the effective FTO inhibitor, competitively prevented the recognition of m6A modified substrate by FTO, which alleviated the growth of subcutaneous breast cancer in mice (33). This evidence concerns the gene FTO and breast carcinoma.